New video on RefluGTM Isorepair, the latest barrier treatment for gastroesophageal reflux

21 June 2021

Discover the innovative mechanism of action of RefluG™ Isorepair, a new patented substance-based medical device (class IIa) designed to quickly reduce gastroesophageal reflux symptoms.

Gastroesophageal reflux disease (GERD) represents a common condition affecting millions of people worldwide with a global prevalence of almost 15%, reaching values higher than 21% in Europe and 28% in the USA. The disruption of the physiological barrier of the esophageal mucosa due to the acid refluxate represents the basis of GERD pathogenesis.

The new video on RefluG™ Isorepair shows how it exerts a protective and regenerative effect on irritated esophageal mucosa. It coats and protects the esophageal mucosa sustaining the physiological healing process of damaged epithelium with mucoadhesive, protective and regenerative effects.

RefluG™ Isorepair is an effective and safe liquid gel preparation, watch the video and discover more about the product!

Fill out the form to contact us

We respond to any technical or commercial request:


    Stay updated on news

    * indicates required